Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now later-stage tilt small index

IUD: later-stage trial registry

4 of 6 indexed IUD trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

IUD: 6 US clinical trials tracked, 4 recruiting.

IUD is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Oregon Health and Science University, running 2 of these trials.

Enrollment posture brief

Registry condition iud

OPEN 4 | RECR 67% | LATE 1 | EARLY 0 | RANK #2866 | SPON 2

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

IUD (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near IUD

IUD lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for IUD on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. IUD is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates IUD research.

    Oregon Health and Science University accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most IUD trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. IUD research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on IUD records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

IUD self-removal guide Other
1 trials
Depo-Provera Drug
1 trials
Contraceptive implant Nexplanon Device
1 trials
LNG IUD Drug
1 trials
Copper T-380 IUD Drug
1 trials
Instructions for IUD Self-Removal Provided to Participant Other
1 trials
Cervical cap with EMLA cream Combination
1 trials
Menstrual disc with EMLA cream Combination
1 trials

US sites by state

Facility locations filed on IUD trials. A trial with sites in several states counts in each.

Oregon 2 trials
Washington 1 trials
Utah 1 trials
Massachusetts 1 trials
Arkansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this IUD page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This IUD condition card totals 6 registered trials; most-linked intervention IUD self-removal guide; top US site state Oregon. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.